SageView Cuts Stake in UnitedHealth Group as Analysts Adjust Ratings

SageView Advisory Group LLC has reduced its stake in UnitedHealth Group Incorporated (NYSE: UNH) by 21.0% during the second quarter of 2023. This move is detailed in the firm’s latest Form 13F filing with the Securities and Exchange Commission (SEC). Following the sale of 2,096 shares, SageView now holds 7,882 shares of the healthcare giant, valued at approximately $2,459,000 at the end of the quarter.

Other institutional investors are also shifting their positions in UnitedHealth Group. Notably, Norges Bank established a new stake worth about $3.84 billion during the second quarter. Similarly, Nuveen LLC acquired a new position valued at approximately $3.85 billion in the first quarter. Dodge & Cox significantly increased its holdings by 117.7% during the second quarter, now owning 8,750,560 shares worth around $2.73 billion. Wellington Management Group LLP also expanded its stake by 10.6%, bringing its total to 25,847,940 shares valued at about $13.54 billion. Amundi increased its position in UnitedHealth Group by 33.8%, now holding 6,191,871 shares worth $1.90 billion. Collectively, institutional investors and hedge funds own 87.86% of the stock.

Analysts Update Price Targets for UnitedHealth Group

Several research firms have recently revised their price targets for UnitedHealth Group. Bank of America raised its target from $350.00 to $390.00, maintaining a “neutral” rating. UBS Group increased its price objective from $378.00 to $430.00, assigning a “buy” rating. Cantor Fitzgerald reiterated an “overweight” rating with a price target of $440.00 in its report. TD Cowen adjusted its target from $335.00 to $338.00, while Royal Bank of Canada raised its target from $286.00 to $408.00 and maintained an “outperform” rating.

A total of 17 analysts have rated UnitedHealth Group with a “buy” rating, while nine issued a “hold” rating and three recommended a “sell.” According to MarketBeat, the stock currently holds a consensus rating of “hold” with an average price target of $385.54.

Performance and Upcoming Dividend Announcement

As of October 28, 2023, UnitedHealth Group’s stock opened at $330.61. The company has experienced a 52-week low of $234.60 and a 52-week high of $606.36. Key financial metrics include a quick ratio of 0.82, a current ratio of 0.82, and a debt-to-equity ratio of 0.71. The firm boasts a market capitalization of $299.48 billion, a price-to-earnings (P/E) ratio of 17.26, and a beta of 0.43.

In its latest earnings report, UnitedHealth Group announced earnings of $2.92 per share, surpassing the consensus estimate of $2.87 by $0.05. The company’s net margin stood at 4.04%, with a return on equity of 19.23%. For the quarter, revenue reached $113.16 billion, slightly below analyst expectations of $113.19 billion. This figure reflects a year-over-year increase of 12.2%.

Additionally, UnitedHealth Group recently declared a quarterly dividend of $2.21 per share, to be distributed on December 16, 2023. Shareholders of record on December 8, 2023 will receive this dividend, representing an annualized payout of $8.84 and a dividend yield of 2.7%. The company’s dividend payout ratio is currently 46.14%.

UnitedHealth Group operates as a diversified health care company within the United States, with four primary segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. Its offerings include health benefit plans for various employer sizes, Medicaid plans, and services for individuals aged 50 and older.

As institutional investors continue to adjust their holdings, UnitedHealth Group remains a key player in the healthcare sector, with analysts closely monitoring its performance and future prospects.